Login / Signup

Heterozygous NOTCH1 Variants Cause CNS Immune Activation and Microangiopathy.

Guy HelmanParand ZarekianiSamantha A M TrompAshley AndrewsLorenzo D BottoJoshua Leith BonkowskyAnna ChasseventElisa GiorgioTommaso PippucciShen WeiConstance Smith-HicksGiovanna VaulaMichel A A P WillemsenMareike SchimmelKurt VollertFumitaka ShimizuTakashi KandaMatthew LynchTony RoscioliRyan J TaftCas SimonsMarianna BugianiTaco W KuijpersMarjo S van der Knaap
Published in: Annals of neurology (2022)
NOTCH1 belongs to the NOTCH family of proteins that regulate cell fate and inflammatory responses. Somatic and germline NOTCH1 variants have been implicated in cancer, Adams-Oliver syndrome, and cardiovascular defects. We describe 7 unrelated patients grouped by the presence of leukoencephalopathy with calcifications and heterozygous de novo gain-of-function variants in NOTCH1. Immunologic profiling showed upregulated CSF IP-10, a cytokine secreted downstream of NOTCH1 signaling. Autopsy revealed extensive leukoencephalopathy and microangiopathy with vascular calcifications. This evidence implicates that heterozygous gain-of-function variants in NOTCH1 lead to a chronic central nervous system (CNS) inflammatory response resulting in a calcifying microangiopathy with leukoencephalopathy. ANN NEUROL 2022;92:895-901.
Keyphrases